Our Promise to You

Guaranteed product quality, expert customer support

Our Promise to You

ONLINE INQUIRY

KM-H2

Cat.No.: CSC-C0104

Species: Human

Source: Hodgkin lymphoma

Morphology: single, round to polygonal cells in suspension; heterogeneity in cell size, bi- and polynucleated cells

Culture Properties: suspension

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
  • Publications
Cat.No.
CSC-C0104
Description
Established from the pleural effusion of a 37-year-old man with Hodgkin lymphoma (mixed cellularity progressing to lymphocyte depletion; stage IV at relapse) in 1974
Species
Human
Source
Hodgkin lymphoma
Recommended Medium
Culture Properties
suspension
Morphology
single, round to polygonal cells in suspension; heterogeneity in cell size, bi- and polynucleated cells
Karyotype
Human hypotriploid karyotype with 3.5% polyploidy - 59(56-60)<3n>der(X)der(Y), -X, -1, -1, -2, -2, -3, -4, -5, -5, -6, -8, -9, -9, -10, -10, -10, -11, -12, -13, -14, -15, -15, -16, -16, -18, -19, -20, -21, -22, +25mar - add(1)(q32), add(3)(q26), add(3)(q2
Quality Control
Mycoplasma: contamination was eliminated with Ciprobay (ciprofloxacin), then negative in DAPI, microbiological culture, RNA hybridization, PCR assays
Immunology: CD2 -, CD3 -, CD13 -, CD14 +, CD15 +, CD19 -, CD21 +, CD30 +, HLA-DR +
Viruses: ELISA: rever
Storage and Shipping
Frozen with 70% medium, 20% FBS, 10% DMSO at about 5 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The KM-H2 cell line is a well-established model system for the study of Hodgkin lymphoma (HL), a type of blood cancer characterized by the presence of Reed-Sternberg cells. This cell line was derived from the pleural effusion of a 37-year-old male patient who was diagnosed with mixed cellularity HL that had progressed to the lymphocyte depletion subtype at the time of relapse in 1974.

By utilizing the KM-H2 cell line, researchers have been able to delve deeper into the genetic and molecular alterations that drive the development and progression of HL. The cell line has been extensively characterized and has proven to be a reliable model for testing the efficacy and mechanisms of action of various therapeutic agents targeting HL.

Furthermore, the KM-H2 cell line has facilitated the understanding of the complex tumor microenvironment in HL, as these cells exhibit interactions with various immune and stromal cell types that contribute to disease pathogenesis. This knowledge has been crucial for the development of novel immunotherapeutic approaches and combination therapies for the management of HL.

Melittin is Toxic for KM-H2 HL Cells

The high toxicity of melittin (MEL) for HL cell lines KM-H2. IC50 values were found to be 0.75 +/− 0.073 µM for KM-H2 cells. The toxicity of MEL for these HL cells was higher than the toxicity for normal blood cells. KM-H2 cells with normal peripheral blood mononuclear cells (PBMC) were co-cultured in the presence of different concentrations of MEL. HL cells and PBMC were discriminated against using their different cell size. As shown in Fig. 1, the percentage of living tumor cells decreased with increasing MEL concentrations. Interestingly, a shift in the composition of the surviving normal PBMCs. As shown in Fig. 2, a strong increase in the monocyte population. This increase was also visible in cultures without HL cells. After staining with specific antibodies, a strong increase in the percentage of CD14-positive monocytes and a less pronounced but significant increase in the percentage of CD56-positive NK cells (Fig. 3). Percentages of CD19-positive B cells and CD8-positive cytotoxic T cells decreased whereas CD4-positive T helper cells remained unchanged.

KM-H2 cells were incubated together with PBMC in the presence or absence of different concentrations of MEL. Cell viability was assessed by flow cytometry. Presented are viable tumor cells as percentages of all living cells.Fig. 1 Toxicity of MEL for HL cell lines KM-H2. (Kreinest T, et al., 2020)

KM-H2 cells, PBMC, and co-cultures of KM-H2 cells and PBMC were incubated with 1.5 µM MEL or medium without MEL. Thereafter, cells were stained with propidium iodide and analyzed by flow cytometry. Presented are representative dot blots of PI-negative living cells.Fig. 2 MEL increases monocyte numbers. (Kreinest T, et al., 2020)

PBMC were treated with 1.5 µM MEL or left untreated and analyzed by flow cytometry using antibodies directed against CD3, CD4, CD8, CD14, and CD56.Fig. 3 Changes in blood cell populations after treatment with MEL. (Kreinest T, et al., 2020)

mir148a Overexpression Decreases Cell Proliferation in KM-H2

To put the observation of mir-148a downregulation in classical HL (cHL) in a functional context, three cHL cell lines stably overexpressed mir-148a (KM-H2, L-540, L-1236) were established.

By analyzing these cell lines using the CCK8 assay, a significant decrease (p < 0.05) in cell proliferation after miR-148a overexpression in the KM-H2 cell line. On day 8 of the experiment, a 32% reduction in cell proliferation was observed in the mir-148a-expressing cell line as compared to cells with the empty vector. miR-148a overexpression did not affect the proliferation of L-1236 and L-540 cell lines (Fig. 4).

To analyze if the decrease in cell proliferation observed using the CCK8 test is related to differences in DNA replication, the flow cytometry assay was conducted based on the measurement of newly synthesized DNA in cells in S-phase. In line with the CCK8 test results, a decrease in DNA synthesis was observed for the KM-H2 cell line. On day 3 of culture, KM-H2 cells transduced with miR-148a expression vector showed a significantly lower percentage of cells with newly synthesized DNA as compared to cells transduced with the empty vector (35% vs. 49%, p = 0.03).

The viability of cHL cell lines (KM-H2, L-540, L-1236) following mir-148a overexpression was assessed using the CCK-8 test.Fig. 4 cHL cell lines (KM-H2, L-540, L-1236) viability after mir-148a overexpression (CCK-8 test). (Paczkowska J, et al., 2020)

What are the different types of circulating tumor cells?

The CTC pool in cancer patients is heterogeneous and may include CTCs belonging to the epithelial type, epithelial-mesenchymal transition (EMT) type, hybrid (epithelial/EMT +) type, irreversible EMT + type, and circulating tumor stem cells.

What is the origin of the KM-H2 cell line?

The KM-H2 cell line was established from the pleural effusion of a 37-year-old male patient who was diagnosed with mixed cellularity Hodgkin lymphoma that had progressed to the lymphocyte depletion subtype at the time of relapse in 1974.

What are the applications of the KM-H2 cell line in Hodgkin lymphoma research?

The KM-H2 cell line is widely used for testing the efficacy and mechanisms of action of novel therapeutic agents targeting Hodgkin lymphoma, as well as for studying the resistance mechanisms to current treatment modalities. It also serves as a platform for developing and evaluating new immunotherapeutic approaches for this disease.

What are the advantages of using the KM-H2 cell line compared to primary Hodgkin lymphoma samples?

The KM-H2 cell line offers several advantages over the use of primary Hodgkin lymphoma samples, including a reliable and consistent supply of cells, the ability to perform large-scale experiments, and the opportunity to study the disease in a more controlled and reproducible manner.

Ask a Question

Average Rating: 4.7    |    3 Scientist has reviewed this product

Well packaged

Once I received the cells, the product was well packaged and labeled.

26 Jan 2023


Ease of use

After sales services

Value for money


Satisfied

I recently ordered the KM-H2 cell line from Creative Bioarray to investigate novel targeted therapies for HL. I am very satisfied with the overall experience and the quality of the KM-H2 products from Creative Bioarray.

25 Jan 2024


Ease of use

After sales services

Value for money


A reliable platform

The consistent growth characteristics and robust response of the KM-H2 cells have been crucial for the success of my experiments, providing a reliable platform for evaluating drug candidates.

13 Feb 2024


Ease of use

After sales services

Value for money


Write your own review

  • You May Also Need

For research use only. Not for any other purpose.